The Motley FoolSat, 04 Apr 2026 23:36:00 GMTMaze Therapeutics' Chief Medical Officer Sold 100% of His Direct Holdings. Here's What This Means for Investors.MAZE+2.20%
Seeking AlphaFri, 27 Mar 2026 19:09:00 GMTMaze Therapeutics: MZE829 Presses Forward Despite Stock Price DropMAZE+2.20%
Zacks Investment ResearchFri, 27 Mar 2026 14:37:11 GMTAfter Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Maze Therapeutics, Inc. (MAZE)MAZE+2.20%
The Motley FoolWed, 25 Mar 2026 18:41:04 GMTMaze Insider Reports $736K Sale. Here's What Investors Should Know as Stock Plunges 33%MAZE+2.20%
BenzingaWed, 25 Mar 2026 17:15:51 GMTMaze Therapeutics Stock Falls Despite Strong Phase 2 Kidney Drug Data For MZE829MAZE+2.20%
The Motley FoolSun, 22 Mar 2026 02:17:49 GMTMaze Therapeutics President Sells All Insider Shares as Q4 Earning Report NearsMAZE+2.20%
The Motley FoolMon, 16 Feb 2026 06:35:14 GMTMaze Therapeutics Chief Medical Officer Sells 15K Shares As Company's Stock Continues to SurgeMAZE+2.20%
